Douglas Macdonald
Overview
Explore the profile of Douglas Macdonald including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1547
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilson H, Macdonald D, Bryce K
Case Rep Gastroenterol
. 2024 Jul;
18(1):347-351.
PMID: 39015527
Introduction: Patients with advanced hepatocellular carcinoma (HCC) have limited treatment options in the context of decompensated cirrhosis. HCC occurs in patients with hepatitis C virus (HCV) infection and cirrhosis at...
2.
DiFiglia M, Leavitt B, Macdonald D, Thompson L
J Huntingtons Dis
. 2024 Jul;
13(2):119-131.
PMID: 38968054
The field of Huntington's disease research covers many different scientific disciplines, from molecular biology all the way through to clinical practice, and as our understanding of the disease has progressed...
3.
Lumley S, Barlow M, Said K, Martyn E, Waddilove E, Delphin M, et al.
Sex Transm Infect
. 2024 Jun;
100(5):329-331.
PMID: 38914475
Diagnosing and treating chronic hepatitis B virus (HBV) infection are key interventions to support progress towards elimination of viral hepatitis by 2030. Although nucleos/tide analogue (NA) therapy is typically highly...
4.
Downs L, Kabagambe K, Williams S, Waddilove E, Delphin M, Lumley S, et al.
J Viral Hepat
. 2024 May;
31(8):490-499.
PMID: 38798022
Chronic hepatitis B infection (CHB) affects 300 million people worldwide and is being targeted by the United Nations 2030 Sustainable Development Goals (SDGs) and the World Health Organisation (WHO), working...
5.
Zeng J, Macdonald D, Durkin R, Irish D, Hart J, Haque T
J Clin Virol
. 2023 Nov;
169:105615.
PMID: 37948983
Background: The National Health Service (NHS) in England commissioned opt-out testing in London Emergency Departments (ED) in April 2022 to allow early identification and management of hepatitis B (HBV) and...
6.
Liu L, Malagu K, Haughan A, Khetarpal V, Stott A, Esmieu W, et al.
J Med Chem
. 2023 Sep;
66(18):13205-13246.
PMID: 37712656
Huntington's disease (HD) is caused by an expanded CAG trinucleotide repeat in exon 1 of the huntingtin () gene. We report the design of a series of pre-mRNA splicing modulators...
7.
Hamill V, Wong S, Benselin J, Krajden M, Hayes P, Mutimer D, et al.
BMJ
. 2023 Aug;
382:e074001.
PMID: 37532284
Objectives: To quantify mortality rates for patients successfully treated for hepatitis C in the era of interferon-free, direct acting antivirals and compare these rates with those of the general population....
8.
Hamill V, Gelson W, Macdonald D, Richardson P, Ryder S, Aldersley M, et al.
Liver Int
. 2023 Jan;
43(4):917-927.
PMID: 36708150
Background: Previous studies show the uptake of biannual ultrasound (US) surveillance in patients with cirrhosis is suboptimal. Here, our goal was to understand in broader terms how surveillance is being...
9.
Bryce K, Smith C, Rodger A, Macdonald D
J Viral Hepat
. 2022 Oct;
30(1):46-55.
PMID: 36197840
Most high-income countries are not on track to achieve the World Health Organization hepatitis C elimination targets. As elimination programmes assess growing proportions of patients in community-based pathways, rates of...
10.
Balde H, Wagner-Riddle C, Macdonald D, VanderZaag A
Waste Manag
. 2022 Aug;
151:123-130.
PMID: 35944429
This study quantified fugitive methane (CH) losses from multiple sources (open digestate storages, digesters and flare) at two biogas facilities over one year, providing a much needed dataset integrating all...